Eric M. Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc. (TVTX), sold 60,000 shares at $30.55 ($1.9M) on 2026-04-01, disclosed to the SEC on 2026-04-02.
Scheduled sale ($1.9M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.55 | 34,902 | $1.1M | 57.5% |
| 2 | $31.46 | 25,098 | $790K | 42.5% |
| Total | $30.93 avg | 60,000 | $1.9M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |
| TVTX | SELL | 2026-02-03 | $3.2M | — | Filing → |